A negative association between SFRP1 expression and cancer progression has also been reported, showing that loss of SFRP1 expression is a promoter of theWnt/β-catenin pathway (Li et al., 2017; Song et al., 2018; Sunkara et al., 2020; Yu et al., 2022). Here, SFRP1 is linked to cancer.